De Monte C - Search Results

1

Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties.

Secci D, Carradori S, Bizzarri B, Chimenti P, De Monte C, Mollica A, Rivanera D, Zicari A, Mari E, Zengin G, Aktumsek A. Secci D, et al. Among authors: de monte c. Eur J Med Chem. 2016 Jul 19;117:144-56. doi: 10.1016/j.ejmech.2016.04.012. Epub 2016 Apr 8. Eur J Med Chem. 2016. PMID: 27100030

2

New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.

De Monte C, Carradori S, Chimenti P, Secci D, Mannina L, Alcaro F, Petzer A, N'Da CI, Gidaro MC, Costa G, Alcaro S, Petzer JP. De Monte C, et al. Eur J Med Chem. 2014 Jul 23;82:164-71. doi: 10.1016/j.ejmech.2014.05.048. Epub 2014 May 22. Eur J Med Chem. 2014. PMID: 24904963

3

Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii.

D'Ascenzio M, Bizzarri B, De Monte C, Carradori S, Bolasco A, Secci D, Rivanera D, Faulhaber N, Bordón C, Jones-Brando L. D'Ascenzio M, et al. Among authors: de monte c. Eur J Med Chem. 2014 Oct 30;86:17-30. doi: 10.1016/j.ejmech.2014.08.046. Epub 2014 Aug 15. Eur J Med Chem. 2014. PMID: 25140751

4

Bioactive compounds of Crocus sativus L. and their semi-synthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents.

De Monte C, Bizzarri B, Gidaro MC, Carradori S, Mollica A, Luisi G, Granese A, Alcaro S, Costa G, Basilico N, Parapini S, Scaltrito MM, Masia C, Sisto F. De Monte C, et al. J Enzyme Inhib Med Chem. 2015 Dec;30(6):1027-33. doi: 10.3109/14756366.2014.1001755. Epub 2015 Sep 4. J Enzyme Inhib Med Chem. 2015. PMID: 25766747 Free article.

5

Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma.

De Monte C, Carradori S, Secci D, D'Ascenzio M, Guglielmi P, Mollica A, Morrone S, Scarpa S, Aglianò AM, Giantulli S, Silvestri I. De Monte C, et al. Eur J Med Chem. 2015 Nov 13;105:245-62. doi: 10.1016/j.ejmech.2015.10.023. Epub 2015 Oct 22. Eur J Med Chem. 2015. PMID: 26498571

6

Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives.

De Monte C, Carradori S, Bizzarri B, Bolasco A, Caprara F, Mollica A, Rivanera D, Mari E, Zicari A, Akdemir A, Secci D. De Monte C, et al. Eur J Med Chem. 2016 Jan 1;107:82-96. doi: 10.1016/j.ejmech.2015.10.048. Epub 2015 Nov 2. Eur J Med Chem. 2016. PMID: 26562544

7

Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives.

Carradori S, Secci D, Bizzarri B, Chimenti P, De Monte C, Guglielmi P, Campestre C, Rivanera D, Bordón C, Jones-Brando L. Carradori S, et al. Among authors: de monte c. J Enzyme Inhib Med Chem. 2017 Dec;32(1):746-758. doi: 10.1080/14756366.2017.1316494. J Enzyme Inhib Med Chem. 2017. PMID: 28537532 Free PMC article.

8

Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity.

Carradori S, Bizzarri B, D'Ascenzio M, De Monte C, Grande R, Rivanera D, Zicari A, Mari E, Sabatino M, Patsilinakos A, Ragno R, Secci D. Carradori S, et al. Among authors: de monte c. Eur J Med Chem. 2017 Nov 10;140:274-292. doi: 10.1016/j.ejmech.2017.09.026. Epub 2017 Sep 19. Eur J Med Chem. 2017. PMID: 28963991

9

Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.

Carradori S, Ortuso F, Petzer A, Bagetta D, De Monte C, Secci D, De Vita D, Guglielmi P, Zengin G, Aktumsek A, Alcaro S, Petzer JP. Carradori S, et al. Among authors: de monte c. Eur J Med Chem. 2018 Jan 1;143:1543-1552. doi: 10.1016/j.ejmech.2017.10.050. Epub 2017 Oct 19. Eur J Med Chem. 2018. PMID: 29126727

10

Synthesis and selective inhibitory activity against human COX-1 of novel 1-(4-substituted-thiazol-2-yl)-3,5-di(hetero)aryl-pyrazoline derivatives.

Carradori S, Secci D, Bolasco A, De Monte C, Yáñez M. Carradori S, et al. Among authors: de monte c. Arch Pharm (Weinheim). 2012 Dec;345(12):973-9. doi: 10.1002/ardp.201200249. Epub 2012 Sep 7. Arch Pharm (Weinheim). 2012. PMID: 22961586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters